title: Increased long-term cardiovascular morbidity among patients treated with radioactive iodine for hyperthyroidism.
abstract: OBJECTIVE
  Previous studies suggest that hyperthyroid patients remain at increased risk of cardiovascular morbidity after restoring euthyroidism. The aim of this study was to compare the rate and causes of hospitalization of hyperthyroid patients treated with radioactive iodine (RAI) with those of an age- and gender-matched reference population in a long-term follow-up study.
  
  
  METHODS
  A population-based cohort study with a median follow-up time of 9 years was conducted among 2611 hyperthyroid patients treated with RAI between 1969 and 2002 in Tampere University Hospital, and among 2611 reference subjects. Information on hospitalizations was obtained from the nationwide Hospital Discharge Registry. New events were analysed as the main outcome, including only the first hospitalization due to a given indication.
  
  
  RESULTS
  The rate of hospitalization due to cardiovascular disease (CVD) was higher among patients with hyperthyroidism than among the control population [637.1 vs. 476.4 per 10 000 person-years, rate ratio (RR) 1.12, 95% confidence interval (CI) 1.03-1.21]. The risk remained elevated up to 35 years after the RAI treatment. Hospitalizations due to atrial fibrillation (RR 1.35), cerebrovascular disease (RR 1.31), diseases of other arteries and veins (RR 1.22), hypertension (RR 1.20) and heart failure (RR 1.48) were more frequent in the patients than controls, while no such difference was found for coronary artery disease. Hospitalizations due to cancer, infectious and gastrointestinal diseases, and fractures were also more common in patients than in controls.
  
  
  CONCLUSIONS
  Hyperthyroidism increases hospitalizations due to CVDs. The excess risk is sustained decades after treatment. Patients treated for hyperthyroidism constitute a high-risk group for CVD and may benefit from preventive interventions.
authors.affiliation: Department of Internal Medicine, Tampere University Hospital, Tampere, Finland. saara.metso@pshp.fi
authors.forename: Saara
authors.initials: S
authors.lastname: Metso
authors.forename: Anssi
authors.initials: A
authors.lastname: Auvinen
authors.forename: Jorma
authors.initials: J
authors.lastname: Salmi
authors.forename: Heini
authors.initials: H
authors.lastname: Huhtala
authors.forename: Pia
authors.initials: P
authors.lastname: Jaatinen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000209:etiology; D016022:Case-Control Studies; D015331:Cohort Studies; D005260:Female; D005387:Finland / Q000453:epidemiology; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications* / Q000188:drug therapy*; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D012307:Risk Factors; D055815:Young Adult
chemical_list: D007457:Iodine Radioisotopes